Granahan Investment Management, LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1026710 WALTHAM, MA

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,111,321

+$1,999,337 QoQ

Shares Held

313,884

+42.3% QoQ

Ownership

0.369%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#38

of 172 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 90% Shared 0% None 10%

Healthcare · as of Jun 30, 2026

Granahan Investment Management, LLC holds $259,488,707 across 26 Biotechnology names. MLTX ranks #17 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	147,231	$46,538,246
2	TWST	Twist Bioscience Corp	314,882	$32,395,060
3	CELC	Celcuity Inc.	179,053	$18,732,524
4	STOK	Stoke Therapeutics, Inc.	461,608	$15,103,813
5	SNDX	Syndax Pharmaceuticals Inc	446,988	$9,771,157
6	RYTM	Rhythm Pharmaceuticals, Inc.	83,270	$9,245,468
7	SRRK	Scholar Rock Holding Corp	163,759	$9,006,745
8	TSHA	Taysha Gene Therapies, Inc.	1,305,177	$8,888,255

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,111,321	313,884	+42.3%	Shares	Sole	2026-08-14
2026-03-31	$4,111,984	220,600	+11.2%	Shares	Sole	2026-05-15
2025-12-31	$2,613,686	198,307	+146.8%	Shares	Sole	2026-02-17
2025-06-30	$3,793,086	80,362	-43.5%	Shares	Sole	2025-08-14
2025-03-31	$5,556,535	142,220	+4.2%	Shares	Sole	2025-05-15
2024-12-31	$7,388,117	136,438	-21.0%	Shares	Sole	2025-02-14
2024-09-30	$8,704,206	172,634	-39.1%	Shares	Sole	2024-11-14
2024-06-30	$12,472,046	283,649	+31.4%	Shares	Sole	2024-08-14
2024-03-31	$10,840,437	215,816	+70.2%	Shares	Sole	2024-05-15
2023-12-31	$7,655,761	126,772	+49.9%	Shares	Sole	2024-02-14
2023-09-30	$4,820,034	84,562	+17.6%	Shares	Sole	2023-11-14
2023-06-30	$3,668,634	71,934	-2.3%	Shares	Sole	2023-08-14
2023-03-31	$1,575,095	73,637	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.